195.인슐린 맞는 사람에게 기쁜 소식을.

The Gospel for Patients Taking Insulin. With the rise of Type 1 diabetes and the increasing number of Type 2 diabetics, who suffer from the disease for a long time, the number of people who are forced to take insulin is also increasing. However, many people are afraid of insulin, which is available only in injectable form. In this situation, demand for more convenient injectable or oral insulin is growing. For pharmaceutical companies, these drugs are a holy grail. Finally, some tangible results have been achieved. Recently, a paper was published showing that a once-weekly insulin passed Phase 2 clinical trials. This is a new drug from Novo Nordisk, a renowned insulin manufacturer. A Phase 2 report on a double-injection insulin was also successfully presented at this year's European Association for the Study of Diabetes. If all goes as planned, Type 1 diabetics and Type 2 diabetics who need or are taking insulin will be in for a wonderful day within the next five to ten years.